KYMOS GROUP is a GLP/GMP-certified, GCP compliant, EMA and FDA-inspected CRO specialized in bioanalysis and CMC. we provide bioanalytics in EU preclinical & clinical trials for small molecules, biologics and oligonucleotides, PK, and full bioequivalence studies. Furthermore KYMOS GROUP offers CMC services for method development, batch testing and release, stability testing, biosimilars comparability and characterization of innovators for clients worldwide. KYMOS GROUP sites are in Barcelona, Ancona, Copenhaguen and Frankfurt.
Sector
Business Developer Iberia
KYMOS, S.L.U.
Service
Bioanalysis of Small Molecules & Generics
Preclinical studies of small molecules Clinical studies of small molecules Percutaneous absorption Residue depletion studies Absorption studies
Business Developer Iberia at KYMOS, S.L.U.
Barcelona, Spain
Service
Bioanalysis & Immunogenicity of Biologics & Biosimilars
Preclinical studies of biologics & biosimilars Clinical studies of biologics & biosimilars Immunogenicity assays
Business Developer Iberia at KYMOS, S.L.U.
Barcelona, Spain
Service
Method Development, Validation, and Transfer (DP, API, excipients...)
Kymos has two GMP-certified, EMA and FDA-inspected EU sites fully dedicated to analytical method development and validation for CMC purposes of small molecules, biologics, and advanced therapies.
Business Developer Iberia at KYMOS, S.L.U.
Barcelona, Spain